PortfoliosLab logo

Atea Pharmaceuticals, Inc. (AVIR)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS04683R1068
CUSIP04683R106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$8.79
Year Range$5.33 - $44.59
EMA (50)$7.74
EMA (200)$11.52
Average Volume$626.83K
Market Capitalization$705.19M

AVIRShare Price Chart


Chart placeholderClick Calculate to get results

AVIRPerformance

The chart shows the growth of $10,000 invested in Atea Pharmaceuticals, Inc. in Nov 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $2,897 for a total return of roughly -71.03%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%MarchAprilMayJuneJulyAugust
27.96%
-7.55%
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AVIRReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M17.36%8.19%
6M29.26%-7.42%
YTD-1.68%-13.03%
1Y-66.94%-5.85%
5Y-50.58%14.44%
10Y-50.58%14.44%

AVIRMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-20.13%-11.20%13.88%-18.70%34.24%-9.90%15.49%7.20%
202174.72%3.23%-18.06%-59.98%-17.36%5.19%16.57%18.69%17.97%-66.80%-30.50%10.51%
20209.82%25.39%

AVIRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Atea Pharmaceuticals, Inc. Sharpe ratio is -0.71. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.71
-0.31
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AVIRDividend History


Atea Pharmaceuticals, Inc. doesn't pay dividends

AVIRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-90.06%
-13.58%
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AVIRWorst Drawdowns

The table below shows the maximum drawdowns of the Atea Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Atea Pharmaceuticals, Inc. is 93.97%, recorded on May 9, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.97%Feb 9, 2021315May 9, 2022
-22.86%Nov 9, 20201Nov 9, 202013Nov 27, 202014
-19.37%Nov 30, 20208Dec 9, 20208Dec 21, 202016
-7.22%Nov 2, 20202Nov 3, 20201Nov 4, 20203
-7.15%Feb 4, 20211Feb 4, 20212Feb 8, 20213
-6.4%Jan 21, 20211Jan 21, 20214Jan 27, 20215
-5.89%Jan 11, 20212Jan 12, 20211Jan 13, 20213
-4.78%Dec 23, 20202Dec 24, 20201Dec 28, 20203
-0.86%Jan 4, 20211Jan 4, 20211Jan 5, 20212

AVIRVolatility Chart

Current Atea Pharmaceuticals, Inc. volatility is 32.00%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%MarchAprilMayJuneJulyAugust
32.00%
19.67%
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)